等待開盤 03-26 09:30:00 美东时间
+2.860
+5.72%
Wall Street analysts changed their outlook on top names. Check analyst ratings page for upgrades, downgrades, and initiations. MDLZ, EVGO, CRGY, ARE, TERN.
18分钟前
HC Wainwright & Co. analyst Andres Y. Maldonado downgrades Terns Pharma (NASDAQ:TERN) from Buy to Neutral and lowers the price target from $60 to $53.
03-25 23:00
Merck is reportedly nearing a $6 billion acquisition of Terns Pharmaceuticals to strengthen its oncology pipeline ahead of Keytruda's patent expiry.
03-25 17:38
Blaize Holdings, Inc.涨55.86%;Next Technology涨28.00%;Braze, Inc. Class A涨20.09%
03-25 10:04
Terns Pharmaceuticals, Inc.涨10.00%,报55.0美元
03-25 09:01
裁员20%+新模型难产,Meta看涨期权占比仍超六成;获Wedbush上调目标价至500美元,美光绩前期权成交活跃>>
03-16 19:20
Terns Pharmaceuticals granted equity inducement awards to two new employees under the 2022 Employment Inducement Award Plan. The awards, totaling options for 312,000 shares of common stock with a $40.40 exercise price, vest over four years. The stock options were approved by the Compensation Committee and comply with Nasdaq Listing Rule 5635(c)(4). Terns is a clinical-stage oncology company focused on innovative cancer treatments.
01-02 21:05
“减肥神药”临床数据引爆!WaVe生命科学周涨121%;福尼克斯周内飙升50%,创历史新高;SpaceX上市传闻引爆市场,太空概念股Planet Labs周涨42.8%>>
2025-12-13 10:07
今日重点评级关注:HC Wainwright & Co.:维持Moleculin Biotech"买入"评级,目标价从4美元升至22美元;HC Wainwright & Co.:上调Soluna Holdings评级至"买入",目标价5美元
2025-12-12 10:24
Terns Pharmaceuticals (TERN) priced an upsized underwritten public offering of 16.25M shares at a public offering price of $40.00 per share. The gross proceeds from the offering are expected to be $65...
2025-12-10 15:20